Sanne Wulff
Glostrup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients.
Journal: Frontiers in neuroscience
Published: January 31, 2020
The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients.
Journal: Psychological medicine
Published: January 16, 2019
Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
Journal: Psychoneuroendocrinology
Published: November 20, 2017
Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy.
Journal: Clinical EEG and neuroscience
Published: November 18, 2017
Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment.
Journal: JAMA psychiatry
Published: January 10, 2016
Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis: A case control study.
Journal: Psychiatry research
Published: September 11, 2015
Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.
Journal: Schizophrenia bulletin
Published: February 21, 2015
Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia.
Journal: Archives of general psychiatry
Published: August 08, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026